Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH07-06-0419
Issue:2008: 99/6 (June) pp. 985-1136
Pages:1013-1018

Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes

Stefan Lethagen1,2, Andreas Hillarp3, Caroline Ekholm2, Eva Mattson2, Christer Halldén3, Britt Friberg4
1Department for Coagulation Disorders, Malmö University Hospital, Sweden; 2Center for Hemostasis and Thrombosis, Copenhagen University Hospital (Rigshospitalet), Denmark; 3Department of Clinical Chemistry, Malmö University Hospital, Malmö, Sweden; 4Department of Obstetrics and Gynecology, Lund University Hospital, Lund, Sweden

Summary

The normal distribution of von Willebrand factor (VWF) levels is wide. Low levels are associated with bleeding symptoms and von Willebrand disease (VWD). We have recently described a high prevalence of bleeding symptoms in a whole age group of young females (n = 1,019) from Malmo, Sweden. It was the objective of the present study to evaluate the distribution of VWF levels in young females with or without bleeding symptoms in this population, and the influence of ABO blood group and promoter haplotypes on VWF levels and to identify a possible increased prevalence of VWD in females with bleeding symptoms. A random selection of the female age group (n = 246), into a study group (n = 176) with, and a control group (n = 70) without bleeding symptoms, was evaluated. Eighteen girls had VWF:RCo below the reference range, of which 17 belonged to the study group (17/176, 9.7%), and one to the control group (1/70, 1.4%) (p = 0.017). Blood group O was found in 14/18 girls with low VWF:RCo. There was a highly significant correlation between VWF:RCo and blood group O and non-O genotypes. Two common VWF promoter haplotypes did not contribute to the VWF:RCo variation. VWF levels did not correlate with time during menstrual cycle, or the use of oral contraceptives. No case fulfilled the diagnostic criteria for VWD. In conclusion, low VWF:RCo was significantly more frequent in females with bleeding symptoms. However, we found no case fulfilling strict diagnostic criteria for VWD. The ABO blood group was a strong modifier, but VWF promoter haplotypes had no association to VWF levels in this population.

Keywords

clinical studies, inherited coagulation disorders, von Willebrand disease, oral contraceptives, menorrhagia

DOI

http://dx.doi.org/10.1160/TH07-06-0419

You may also be interested in...

1.

E. M. De Wee (1), H. M. Knol (2, 3), E. P. Mauser-Bunschoten (4), J. G. van der Bom (5, 6), J. C. J. Eikenboom (5, 7), K. Fijnvandraat (8), A. De Goede-Bolder (9), B. Laros-van Gorkom (10), P. F. Ypma (11), S. Zweegman (12), K. Meijer (2), F. W. G. Leebeek (1), for the WiN study group

Thrombosis and Haemostasis 2011 106 5: 885-892

http://dx.doi.org/10.1160/TH11-03-0180

2.

M. V. Ragni (1, 2), R. C. Jankowitz (1), K. Jaworski (2), E. P. Merricks (3), M. T. Kloos (3), T. C. Nichols (3)

Thrombosis and Haemostasis 2011 106 4: 641-645

http://dx.doi.org/10.1160/TH11-04-0274

3.

G. Castaman (1), A. Tosetto (1), A. B. Federici (2), F. Rodeghiero (1)

Thrombosis and Haemostasis 2011 105 4: 647-654

http://dx.doi.org/10.1160/TH10-11-0697



Articles

You've 316 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...